« Logout | Web Universe | Contact Us |

About Cipralex Key publications For your patients Q & A Prescribing information

You are here:

Home » Key publications » Key publications within anxiety » Superior Efficacy

Superior Efficacy within anxiety disorders

Escitalopram and paroxetine in the treatment of generalised anxiety disorder

Baldwin et al., Br J Psych 2006 Sep; 189, 264-272

Escitalopram versus Paroxetine for social anxiety disorder: An analysis of efficacy for different symptom dimensions

Stein et al., Eur Neuropsychopharmacol. 2006 Jan;16(1):33-8

A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.

Montgomery et al., J Clin Psychiatry. 2005 Oct;66(10):1270-8.

Treatment of Generalized Anxiety Disorder with Escitalopram: Pooled Results from Double-blind, Placebo-controlled Trials

Goodman WK, Bose A, Wang Q, Journal of Affective Disorders 2005; 161-167

Efficacy and Tolerability of Escitalopram in 12- and 24-week Treatment of Social Anxiety Disorder: Randomised, Double-blind, Placebo-controlled, Fixed-dose study

Lader et al., Depression and Anxiety 2004; 19: 241-248

Prevention of relapse in generalized anxiety disorder by escitalopram treatment

Allgulander, International Journal of Neuropsychopharmacology 2005; 9: 1-11

Escitalopram and Paroxetine Compared to Placebo in the Treatment of Generalised Anxiety Disorder (GAD)

Baldwin et al., Clinical Neuroscience Division, University of Southampton, UK; H.Lundbeck A/S, Copenhagen, Denmark; H.Lundbeck A/S, Lysaker, Norway.

Last updated: 23.05.2006

Key publications

Key publications within depression

Key publications within anxiety

Superior Efficacy

Excellent Tolerability

Fast Onset of Action

Unique Serotonin Dual-Action

Key publications within Obsessive Compulsive Disorder (OCD)

Literature Search

PubMed
Google Scholar